Signaling pathways
-
BA4898 VVD-118313Summary: VVD-118313 is a potent and selective inhibitor. - BA4899 PovorcitinibSummary: Povorcitinib (INCB54707) is a potent and selective inhibitor effective in reducing abscesses and inflammatory nodules.
- BA4900 SAR-20347Summary: An inhibitor.
- BA4901 IzencitinibSummary: Izencitinib (TD-1473) is an orally active, non-selective, gut-limited inhibitor.
- BA4902 BD750Summary: BD750 is a potent immunosuppressant.
- BA4903 SolcitinibSummary: Solcitinib is an orally available, competitive, potent, and selective inhibitor.
- BA4904 SJ10542Summary: SJ10542 is an effective selectively oriented phenylglutarimide (PG)-PROTAC with 14, 11 and 24 nM for JAK2, JAK3 and JAK2-fusionALL, respectively.
- BA4905 JAK2-IN-6Summary: JAK2-IN-6, a polysubstituted aminothiazole derivative, is a potent and selective inhibitor.
- BA4906 TyK2-IN-2Summary: TyK2-IN-2 (Compoud18) is a potent and selective inhibitor.
- BA4907 SJ988497Summary: SJ988497 is a JAK2 degrader.